Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Droloxifene (3-hydroxytamoxifen) has membrane antioxidant ability: potential relevance to its mechanism of therapeutic action in breast cancer — Helen Wiseman (1992) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Droloxifene (3-hydroxytamoxifen) has membrane antioxidant ability: potential relevance to its mechanism of therapeutic action in breast cancer
Shared by
Barry Halliwell
National University of Singapore
Droloxifene (3-hydroxytamoxifen) has membrane antioxidant ability: potential relevance to its mechanism of therapeutic action in breast cancer
Article
1992
en
Authors
+3 more
HW
Helen Wiseman
CS
Cheryl Smith
Barry Halliwell
National University of Singapore
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1997
Antioxidant Action of Ergothioneine: Assessment of Its Ability to Scavenge Peroxynitrite
Okezie I. Aruoma
,
Matthew Whiteman
,
Timothy G. England
,
Barry Halliwell
Biochemical and Biophysical Research Communications
Article
1993
Enhancement by tamoxifen of the membrane antioxidant action of the yeast membrane sterol ergosterol: relevance to the antiyeast and anticancer action of tamoxifen
Helen Wiseman
,
Michael Cannon
,
H. R. V. Arnstein
,
Barry Halliwell
Article
2021
Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications
Beshara Sheehan
,
Christina Guo
,
Antje Neeb
,
Alec Paschalis
,
Shahneen Sandhu
,
Johann S. de Bono
Article
1993
Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?
Helen Wiseman
,
George Paganga
,
Catherine Rice‐Evans
,
Barry Halliwell
Article
2025
Gynecomastia and Its Potential Progression to Male Breast Cancer: Mechanisms, Genetic Factors, and Hormonal Interactions
Ding‐Yi Fu
,
Huijie Miao
,
Zhong Lin Wang
,
Chuang Yang
Discussion(0)
No comments yet. Be the first to comment.